ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Sanjivani Paranteral Earnings Call: Key Takeaways

Sanjivani Paranteral's Q4 & FY26 presentation shows significant decline in standalone financials. Focus remains on injectables (53.5% FY26 revenue) and export markets (78.5% FY26 revenue).

Why this was an Alfa AlertNot a filter event. Financials showed significant YoY decline; no guidance beat reported.
Highlights
Revenue growthFY26 Revenue: INR 647.6 mn (down 7.6% YoY)
MarginsEBITDA down 8.1% in FY26; Q4 EBITDA down 45.6%
Demand visibilityStrong export focus (~75% revenue share)

Growth

Q4 revenue down 42.2%, PAT down 57.2% YoY. FY26 revenue fell 7.6%, PAT dropped 14.6% YoY.

Outlook

Ongoing expansion with new plants in Prague and Pune (2025). Expanding into high-margin IV infusions.

Risks

Substantial year-on-year declines in revenue and profitability across all primary standalone metrics during FY26.

Source

Earnings Call filed with BSE, NSE: SANJIVIN. Summary written with AI assistance from the document.

Read the document ↗

Sanjivani Paranteral Ltd: key numbers

Share price
₹178.55
Market cap
₹219.3 Cr
Revenue (annual)
₹68.67 Cr
Net profit (annual)
₹6.79 Cr
P/E (TTM)
24.5×Sector 43.8×
Promoter holding
31.56%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sanjivani Paranteral Ltd

All →
14:17 IST BSE
Financial Results

Sanjivani Paranteral Q2 FY27 Results: Net Profit ₹4.1 Cr, Up 156.2% YoY

Sanjivani Paranteral Ltd reported revenue from operations of ₹25.3 Cr (+63.2% YoY) and net profit of ₹4.1 Cr (+156.2% YoY) for Q2 FY27.

Key figure
Net profit ₹4.1 Cr · +156.2% YoY
15:48 IST BSE
Fund Raise

Sanjivani Paranteral Fund Raise

Sanjivani Paranteral clarified the objects of its proposed 5 lakh convertible warrant issue to BSE. Proceeds of ~₹5.80 Cr will fund capex and subsidiary working capital for expansion.